Related Experiment Video
Updated: May 13, 2026
11:39
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
Analysis of FOXO1 mutations in diffuse large B-cell lymphoma
Diane L Trinh1, David W Scott, Ryan D Morin
1Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada.
Blood
|March 6, 2013
Summary
FOXO1 mutations are found in 8.6% of diffuse large B-cell lymphoma (DLBCL) cases. These mutations impact survival, particularly in low-risk patients, identifying FOXO1 as a novel prognostic factor in DLBCL.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma, with a cure rate around 60%.
- Previous research indicated the presence of FOXO1 mutations in non-Hodgkin lymphoma samples.
- Understanding genetic alterations is crucial for improving DLBCL prognostication and treatment.
Purpose of the Study:
- To investigate the frequency and impact of FOXO1 mutations in DLBCL.
- To determine the specific regions of FOXO1 affected by mutations and their functional consequences.
- To assess the prognostic significance of FOXO1 mutations in DLBCL patient survival.
Main Methods:
- Analysis of FOXO1 status in 279 DLBCL patient samples and 22 DLBCL cell lines.
- Characterization of mutation locations, including exon 1, N-terminal region, and Forkhead DNA binding domain.
- Assessment of functional effects, such as T24 phosphorylation, 14-3-3 interaction, and nuclear retention.
- Statistical analysis of FOXO1 mutation association with overall survival, considering cell of origin (COO) and revised International Prognostic Index (R-IPI).
Main Results:
- FOXO1 mutations were identified in 8.6% of DLBCL cases.
- Recurrent mutations were predominantly found in the N-terminal region and Forkhead DNA binding domain.
- N-terminal mutations led to decreased T24 phosphorylation, impaired 14-3-3 interaction, and nuclear retention of FOXO1.
- FOXO1 mutation was significantly associated with decreased overall survival (P = .037) in patients treated with standard chemotherapy, independent of COO and R-IPI.
- This association was particularly strong in low-risk R-IPI categories (P = .003).
Conclusions:
- FOXO1 mutations represent a novel and independent prognostic factor in DLBCL.
- These mutations play a significant role in DLBCL pathogenesis.
- Targeting FOXO1 may offer new therapeutic strategies for DLBCL patients, especially those with poor prognostic indicators.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...